Rocket Lab Corp (RKLB) received a notice that officer Arjun Kampani intends to sell 6,034 shares of Rocket Lab common stock under Rule 144. The shares, held as restricted stock units, are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, with an indicated aggregate market value of $399,330.12 as of the filing.
The notice also lists prior Rocket Lab share sales by Arjun Kampani during the preceding three months, including 7,754 shares for $539,896.23, 88,000 shares for $9,502,240.00, and 23,804 shares for $3,509,510.40, the last identified as 10b5-1 sales.
Rocket Lab Corp (RKLB) had a notice filed under Rule 144 for a planned sale of its common stock by officer Frank Klein. The notice covers 35,558 shares to be sold through Morgan Stanley Smith Barney, with an indicated aggregate market value of $2,353,228.44. The issuer’s common shares outstanding are listed as 598,350,482 as of August 27, 2026. The filing also reports that Klein sold 45,692 shares on August 24, 2026 for $3,181,443.24, and 36,860 shares on May 28, 2026 for $5,433,997.04.
Rocket Lab Corp (RKLB) disclosed that Chief Financial Officer Adam C. Spice sold a total of 9,677 shares of common stock on August 24, 2026 in a series of open-market transactions. According to the disclosure, all sales were part of a sell-to-cover arrangement under a Rule 10b5-1 trading plan to satisfy tax withholding obligations arising from the vesting and settlement of previously granted restricted stock units. The reported weighted-average sale prices ranged from about $69.00 to $71.17 per share. Following these transactions, an indirect holding of 250,000 shares is reported as held by a trust.
Rocket Lab Corp (RKLB) disclosed that officer Agostino Ricupati, VP Corp Controller & CAO, reported three open‑market sales of common stock on 2026-08-24 totaling 669 shares. All transactions were designated as a sell-to-cover to satisfy tax withholding obligations from vesting restricted stock units previously granted to him.
The sales covered 619 shares at a weighted-average price of $69.5345, 20 shares at $70.2023, and 30 shares at $71.1700. Two of the trades were executed across multiple prices within disclosed ranges, and the filing does not state Ricupati’s share balance after these transactions.
Rocket Lab Corp (RKLB) reported that Chief Operations Officer Frank Klein sold a total of 45,692 shares of common stock on 2026-08-24. The transactions were described as sell-to-cover sales under a Rule 10b5-1 election to satisfy tax withholding obligations arising from the vesting and settlement of previously granted restricted stock units. Sale prices were reported as weighted-average prices within disclosed intraday ranges.
Rocket Lab Corp (RKLB) disclosed that SVP & General Counsel Arjun Kampani reported three open‑market sales of common stock on August 24, 2026, totaling 7,754 shares. According to the filing, the transactions were "sell‑to‑cover" sales made under a Rule 10b5‑1 election to satisfy tax withholding obligations related to vesting restricted stock units.
Rocket Lab Corp (RKLB) reported that Marvin Bradford Clevenger, President of Rocket Lab USA, Inc., sold 15,051 shares of common stock on 2026-08-24 in three open-market transactions at weighted-average prices of $69.5345, $70.2023, and $71.1700 per share. According to the disclosure, these were sell-to-cover sales to satisfy tax withholding obligations arising from the vesting and settlement of previously granted restricted stock units, and were effected pursuant to a Rule 10b5-1 trading plan.
Rocket Lab Corp (RKLB) has filed a merger proxy/prospectus covering its agreed acquisition of Iridium Communications Inc. Iridium will become an indirect, wholly owned subsidiary of Rocket Lab and its stock will be delisted from Nasdaq after closing.
Each Iridium share will be converted into the right to receive $27.00 in cash plus Rocket Lab common stock based on an exchange ratio capped by a collar: 0.4000 shares if the Rocket Lab stock price is ≤ $67.50, 0.2400 shares if ≥ $112.50, and otherwise $27.00 divided by the Rocket Lab stock price. No fractional Rocket Lab shares will be issued; cash will be paid in lieu of fractions.
The merger requires approval by a majority of Iridium shares outstanding at a virtual special meeting on September 24, 2026, with a record date of August 21, 2026, and is subject to regulatory clearances and other customary conditions. Rocket Lab plans to fund the cash consideration using balance sheet cash and external financing, including commitments for a $3.6 billion senior secured bridge facility. If certain termination scenarios occur, Iridium must pay Rocket Lab a $223.6 million termination fee.
Rocket Lab Corp (RKLB) received a notice under Rule 144 that officer Adam C. Spice plans to sell common stock. The notice lists a proposed sale of 17,207 Rocket Lab common shares, expected on 08/22/2026, arising from Restricted Stock Vesting as compensation. The remarks state that the sale includes an amount needed to cover a tax obligation from the settlement of a vested equity award distribution.
The notice also reports that during the prior three months, on 05/26/2026, Adam Spice sold 62,744 Rocket Lab common shares for total proceeds of $8,945,632.63. The current Form 144 is signed by Arjun Kampani as Attorney-in-Fact for Adam Spice and dated 08/24/2026.